Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why CurveBeam Technology is Even Changing the Way We Talk

Languages are constantly shifting and changing. As our experiences change, new terminology and ways to express the world around us are required. In a time when the medical field is experiencing technological breakthroughs that redefine the way we treat patients, it should be no surprise that the language used in some medical fields may quickly…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Languages are constantly shifting and changing. As our experiences change, new terminology and ways to express the world around us are required. In a time when the medical field is experiencing technological breakthroughs that redefine the way we treat patients, it should be no surprise that the language used in some medical fields may quickly become outdated.

Nowhere is this truer than in orthopedic pathology diagnoses. In January’s issue of the Lower Extremity Review (LER), Ian Engelman’s article “Saying ‘PTTD” Is Misleading: It’s time for a new lexicon to distinguish pathologies” focuses on just one segment of the field to show the issues inherent in the current vocabulary. One of the main problems, for instance, is that the words used to describe what is occurring vary from profession to profession. This means that an orthopedic surgeon, a podiatrist and a physical therapist could all be discussing the same issue, but each use a different, and sometimes conflicting, term for the same pathology.

Engleman argues that as our ability to understand what is occurring in the foot progresses, our language should to. He refers to the organizing principle, stating that, “Better and more specific terms lead to better, more specific understanding of the origin of the pathological condition.” (Engelman, 2018). So much of our language regarding the movement of and connections within the foot regard on comparisons to mechanics in our everyday lives, such as a set of hinges or a mechanical bridge. By merely making analogies, rather than creating a specific and universal set of terms based on careful analysis, misdiagnoses or improper treatment can occur.

According to Engelman we are coming up on a paradigm shift in the world of orthopedics. This is primarily due to the integration of 3D imaging into the treatment of the lower extremities. CurveBeam’s pedCAT technology, Engelman says, is particularly groundbreaking as it allows for 3D, weight-bearing analysis, eliminating much of the guesswork about how the parts of the foot are operating in real-life conditions.

Engelman’s article highlights the limitations placed by utilizing a 2D vocabulary in a field that is beginning to integrate 3D technology. He gives suggestions for how he would linguistically alter the terms used by the industry:

  • “Normal foot” – This one may seem obvious, but before the capabilities provided by 3D scanning technology there was no way to establish a true baseline. Now there is a way to establish the ideal interactions and alignments within a patient’s foot to determine how far away from the norm they are.
  • “Talar escape” – This term is used to describe a spring ligament failure. While this aberration is easier to identify than most, the terms for it have traditionally varied across specialties
  • “Lateral Column Flat Foot” – In the past, much of the reason given for plantar ligamentous failure has been directed towards the medial column within the foot. When examined closer using modern technology, however, Engelman notes that there can be healthy medial columns while flat footedness still occurs, meaning the causality lies more with the ligament interacting with the lateral column. Engelman suggests several terms like this, where there is a linguistic need for events previously not recognized with 2D scans.

As well as making efforts to improve and expand the professional vocabulary, Engelman also urges clinics to begin to implement devices like the CurveBeam pedCAT and CubeVue software. That way there can at least be a visual representation of exactly what is occurring in a patient’s foot, even if there is not yet a way to put it into words. To learn more about CurveBeam’s innovative products, visit http://www.curvebeam.com/ and see how 3D imaging can revolutionize your clinic’s treatment practices.

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512